Based on evidences that Glp1r KO mice and GLP-1RA-treated osteoporotic mice, exhibit modifications of bone quality (12–14), we hypothesized that GLP-1RAs could improve bone quality in T2DM. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.